These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25925198)

  • 1. L-arginine exacerbates experimental cerebral malaria by enhancing pro-inflammatory responses.
    Xu H; Feng Y; Chen G; Zhu X; Pang W; Du Y; Wang Q; Qi Z; Cao Y
    Tohoku J Exp Med; 2015 May; 236(1):21-31. PubMed ID: 25925198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural regulatory T cells mediate the development of cerebral malaria by modifying the pro-inflammatory response.
    Wu JJ; Chen G; Liu J; Wang T; Zheng W; Cao YM
    Parasitol Int; 2010 Jun; 59(2):232-41. PubMed ID: 20219695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplement of L-Arg improves protective immunity during early-stage Plasmodium yoelii 17XL infection.
    Zhu X; Pan Y; Li Y; Cui L; Cao Y
    Parasite Immunol; 2012; 34(8-9):412-20. PubMed ID: 22709481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
    Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
    J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of CD4+ Effector Responses by Naturally Occurring CD4+ CD25+ Foxp3+ Regulatory T Cells Contributes to Experimental Cerebral Malaria.
    Blanc AL; Keswani T; Gorgette O; Bandeira A; Malissen B; Cazenave PA; Pied S
    Infect Immun; 2016 Jan; 84(1):329-38. PubMed ID: 26553468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-existing Schistosoma japonicum infection alters the immune response to Plasmodium berghei infection in C57BL/6 mice.
    Wang ML; Cao YM; Luo EJ; Zhang Y; Guo YJ
    Malar J; 2013 Sep; 12():322. PubMed ID: 24034228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylhydrazine administration accelerates the development of experimental cerebral malaria.
    Zhu X; Liu J; Feng Y; Pang W; Qi Z; Jiang Y; Shang H; Cao Y
    Exp Parasitol; 2015 Sep; 156():1-11. PubMed ID: 26005191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
    Keswani T; Bhattacharyya A
    Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-4Rα signaling by CD8α
    Wu X; Brombacher F; Chroneos ZC; Norbury CC; Gowda DC
    J Biol Chem; 2021; 296():100615. PubMed ID: 33798555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
    Brant F; Miranda AS; Esper L; Gualdrón-López M; Cisalpino D; de Souza DDG; Rachid MA; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
    Brain Behav Immun; 2016 May; 54():73-85. PubMed ID: 26765997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic treatment of L-Arg improves malaria outcomes by regulating host immune responses during Plasmodium yoelii 17XL infection.
    Wang Q; Feng Y; Sun X; Pang W; Fu W; Cao Y
    Exp Parasitol; 2018 Dec; 195():1-7. PubMed ID: 30266573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.
    Schmidt KE; Kuepper JM; Schumak B; Alferink J; Hofmann A; Howland SW; Rénia L; Limmer A; Specht S; Hoerauf A
    PLoS One; 2018; 13(2):e0192717. PubMed ID: 29438386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice.
    Liu Y; Chen Y; Li Z; Han Y; Sun Y; Wang Q; Liu B; Su Z
    Eur J Immunol; 2013 Nov; 43(11):2907-18. PubMed ID: 23893352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Toll-like receptors by chloroquine protects mice from experimental cerebral malaria.
    Zhu X; Pan Y; Li Y; Jiang Y; Shang H; Gowda DC; Cui L; Cao Y
    Int Immunopharmacol; 2012 Aug; 13(4):392-7. PubMed ID: 22659438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis.
    Nie CQ; Bernard NJ; Schofield L; Hansen DS
    Infect Immun; 2007 May; 75(5):2275-82. PubMed ID: 17325053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Virus Hosted in Malaria-Infected Blood Protects against T Cell-Mediated Inflammatory Diseases by Impairing DC Function in a Type I IFN-Dependent Manner.
    Hassan A; Wlodarczyk MF; Benamar M; Bassot E; Salvioni A; Kassem S; Berry A; Saoudi A; Blanchard N
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TGF-β and IL-6 in dendritic cells, Treg and Th17 mediated immune response during experimental cerebral malaria.
    Keswani T; Sarkar S; Sengupta A; Bhattacharyya A
    Cytokine; 2016 Dec; 88():154-166. PubMed ID: 27632786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12Rβ2 is essential for the development of experimental cerebral malaria.
    Fauconnier M; Palomo J; Bourigault ML; Meme S; Szeremeta F; Beloeil JC; Danneels A; Charron S; Rihet P; Ryffel B; Quesniaux VF
    J Immunol; 2012 Feb; 188(4):1905-14. PubMed ID: 22238458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.
    Canavese M; Dottorini T; Crisanti A
    Pathog Glob Health; 2015 Sep; 109(6):255-65. PubMed ID: 26392042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of anti-malaria immunity by vitamin A in C57BL/6J mice infected with heterogenic plasmodium.
    Chen G; Du YT; Liu JH; Li Y; Zheng L; Qin XS; Cao YM
    Int Immunopharmacol; 2019 Nov; 76():105882. PubMed ID: 31520991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.